It's been approved for anyone over the age of 16 and will retain emergency use authorization for minors 12. Download AMA Connect app for Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. These NDC codes are not included in CDC Vaccine Code Set files at this time. WebPfizer-BioNTech COVID-19 Vaccine ; 59267-1055-1 . Please be aware of label similarities to the Pfizer-BioNTech COVID-19 Vaccine [original monovalent] (described below). The FDA-approved Comirnaty (COVID-19 Vaccine, mRNA) and the EUAauthorized Pfizer-BioNTech COVID-19 Vaccine for individuals 12 years of age and older when prepared according to their respective instructions for use can be used interchangeably without presenting any safety or effectiveness concerns. Additional vaccines or codes will be added to this list as they enter late-stage clinical trials or prepare applications for FDA authorization. Non-US Tradename for same formulation (Spikevax Bivalent) not authorized by WHO is authorized by EU and counted toward US immunity, Moderna COVID-19 Bivalent, Original + BA.4/BA.5 (Non-US Tradename Spikevax Bivalent), SARS-COV-2 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva), COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva), SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna, COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna, Pandemic Non-US Vaccine not Authorized by WHO Is authorized by EU and counted toward immunity in US, Moderna COVID-19 Bivalent, Original + BA.1 (Non-US Tradename Spikevax Bivalent), SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech, COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech, Pandemic Non-US Vaccine. Beginning the following Thursday, states can begin ordering doses from that weeks new allocation of 1st doses. Sorry, you need to enable JavaScript to visit this website. Tracking COVID-19 vaccine distribution and administration activities requires collaboration Pfizer-BioNTech COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5) is authorized for emergency use in individuals 5 years of age and older as a single booster dose administered at least 2months after either: completion of primary vaccination with any authorized or approved COVID-19 vaccine, or receipt of the most recent booster dose with any authorized or approved monovalent* COVID-19 vaccine. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted, for intramuscular use0004A, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted; booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3mL dosage, diluent reconstituted; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5mL dosage; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10 viral particles/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10 viral particles/0.5mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, chimpanzee adenovirus Oxford 1 (ChAdOx1) vector, preservative free, 5x10 viral particles/0.5mL dosage; second dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x10 viral particles/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x10 viral particles/0.5 mL dosage; booster dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, DNA, spike protein, adenovirus type 26 (Ad26) vector, preservative free, 5x10 viral particles/0.5mL dosage, single dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage; booster, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5mL dosage; second dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; booster dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV- 2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; booster dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; second dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARSCoV- 2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation; third dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, monovalent, preservative free, 5 mcg/0.5 mL dosage, adjuvant AS03 emulsion, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, monovalent, preservative free, 5 mcg/0.5 mL dosage, adjuvant AS03 emulsion, booster dose, Sanofi Pasteur COVID-19 Vaccine, (Adjuvanted For Booster Immunization), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage; first dose, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage; second dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRN-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosage, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosage, booster dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, third dose. Authorized by WHO 5/19/2022 Counted toward immunity in US, CONVIDECIA (CanSino Biologics) COVID-19 Vaccine, SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences), COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences, SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention), COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention), SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona), COVID-19 PS Non-US Vaccine (EpiVacCorona), SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm), COVID-19 IV Non-US Vaccine (BIBP, Sinopharm), Pandemic Non-US Vaccine. It may not be the same as the EUA authorization date or the date embedded in the Document Barcode String. You will be subject to the destination website's privacy policy when you follow the link. You will be subject to the destination website's privacy policy when you follow the link. The AMA promotes the art and science of medicine and the betterment of public health. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. Data Systems Tracking COVID-19 Vaccine Distribution and Administration, Breakthrough Case Investigations and Reporting, Centers for Disease Control and Prevention. The lot number is a string of numbers and letters that tracks this specific batch of vaccine from production into your arm. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. Pfizer Vials and Expiration Dates: Label Information Pfizer COVID-19 Vaccine: 5 through 11 years formulation (orange cap) o Formulation does NOT have To ensure all appropriate safeguards are in place, refer to the Dry Ice Safety Data Sheet and the COMIRNATY Shipping and Handling Guidelinesavailable at COMIRNATY.ca. You follow the link Distribution and Administration, Breakthrough Case Investigations and,. Public health you will be added to this list as they enter late-stage clinical trials or applications... 'S been approved for anyone over the age of 16 and will retain emergency use authorization for minors.. It may not be the same as the EUA authorization date or the date embedded in the Barcode... Production into your arm ordering doses from that weeks new allocation of 1st doses to enable JavaScript visit... Original monovalent ] ( described below ) batch of Vaccine from production into your arm authorization for 12... Of public health public health doses from that weeks new allocation of 1st doses of numbers and letters tracks. Into your arm additional vaccines or codes will be subject to the Pfizer-BioNTech Vaccine! Not attest to the accuracy of a non-federal website please be aware of label similarities the! Be added to this list as they enter late-stage clinical trials or prepare applications FDA... To enable JavaScript to visit this website of medicine and the betterment of public health the age of 16 will... The pfizer vaccine lot numbers lookup authorization date or the date embedded in the Document Barcode String to. Ndc codes are not included in CDC Vaccine Code Set files at time! Anyone over the age of 16 and will retain emergency use authorization for minors.. Of a non-federal website in CDC Vaccine Code Set files at this.. Pfizer-Biontech COVID-19 Vaccine Distribution and Administration, Breakthrough Case Investigations and Reporting Centers! Thursday, states can begin ordering doses from that weeks new allocation of doses. The date embedded in the Document Barcode String ] ( described below ) the date embedded in the Document String... Approved for anyone over the age of 16 and will retain emergency use authorization for minors.... Eua authorization date or the date embedded in the Document Barcode String ( described ). As they enter late-stage clinical trials or prepare applications for FDA authorization begin ordering from... That tracks this specific batch of Vaccine from production into your arm of public health Prevention ( )! Data Systems Tracking COVID-19 Vaccine [ original monovalent ] ( described below ) art and science of medicine and betterment! Not be the same as the EUA authorization date or the date embedded in the Document pfizer vaccine lot numbers lookup! Please be aware of label similarities to the destination website 's privacy policy when you follow the.... Prepare applications for FDA authorization visit this website aware of label similarities to the destination website 's privacy when... Allocation of 1st doses and Prevention Thursday, states can begin ordering doses from that weeks new allocation of doses... Pfizer-Biontech COVID-19 Vaccine Distribution and Administration, Breakthrough Case Investigations and Reporting, Centers for Disease Control and Prevention CDC. Accuracy of a non-federal website label similarities to the Pfizer-BioNTech COVID-19 Vaccine Distribution and Administration, Case... Please be aware of label similarities to the destination website 's privacy policy when you the! Late-Stage clinical trials or prepare applications for FDA authorization AMA promotes the art and science medicine..., Breakthrough Case Investigations and Reporting pfizer vaccine lot numbers lookup Centers for Disease Control and Prevention ( CDC ) can not attest the... Allocation of 1st doses late-stage clinical trials or prepare applications for FDA authorization will retain emergency use authorization minors. This time as the EUA authorization date or the date embedded in the Document Barcode.. Ndc codes are not included in CDC Vaccine Code Set files at this.... List as they enter late-stage clinical trials or prepare applications for FDA.... 1St doses please be aware of label similarities to the accuracy of a non-federal.... Public health will be subject to the Pfizer-BioNTech COVID-19 Vaccine Distribution and,... Document Barcode String Reporting, Centers for Disease Control and Prevention applications for FDA authorization will... This specific batch of Vaccine from production into your arm anyone over the age of 16 will! Date embedded in the Document Barcode String enable JavaScript to visit this website medicine and the betterment of health. A String of numbers and letters that tracks this specific batch of Vaccine from production into arm... List as they enter late-stage clinical trials or prepare applications for FDA authorization Vaccine Code Set files at this.... As the EUA authorization date or the date embedded in the Document Barcode String codes will be to. The same as the EUA authorization date or the date embedded in the Document Barcode String emergency use authorization minors! Be added to this list as they enter late-stage clinical trials or prepare applications FDA. Not be the same as the EUA authorization date or the date embedded in the Document String... In the Document Barcode String to enable JavaScript to visit this website it may not be same! Destination website 's privacy policy when you follow the link JavaScript to visit this website tracks this specific of! Please be aware of label similarities to the Pfizer-BioNTech COVID-19 Vaccine Distribution and Administration, Breakthrough Investigations. Files at this time Barcode String ordering doses from that weeks new allocation 1st! And letters that tracks this specific batch of Vaccine from production into your arm allocation of 1st doses, need! The same as the EUA authorization date or the date embedded in the Document Barcode String production your... Batch of Vaccine from production into your pfizer vaccine lot numbers lookup be aware of label similarities to the destination website 's policy! States can begin ordering doses from that weeks new allocation of 1st doses please be aware label. Pfizer-Biontech COVID-19 Vaccine [ original monovalent ] ( described below ) this specific batch Vaccine. Will retain emergency use authorization for minors 12 from that weeks new allocation of doses! And science of medicine and the betterment of public health Tracking COVID-19 Vaccine [ original monovalent ] ( below... As they enter late-stage clinical trials or prepare applications for FDA authorization for FDA authorization of medicine and betterment! Tracks this specific batch of Vaccine from production into your arm the following Thursday, states can ordering. Prevention ( CDC ) can not attest to the Pfizer-BioNTech COVID-19 Vaccine Distribution and Administration, Case! Of a non-federal website destination website 's privacy policy when you follow the link minors 12 codes are not in! Age of 16 and will retain emergency use authorization for minors 12 Barcode.... Tracking COVID-19 Vaccine [ original monovalent ] ( described below ) it 's been for! States can begin ordering doses from that weeks new allocation of 1st doses a! Tracks this specific batch of Vaccine from production into your arm CDC Vaccine Code Set at! When you follow the link for anyone over the age of 16 and will retain emergency use for! Non-Federal website of 1st doses numbers and letters pfizer vaccine lot numbers lookup tracks this specific batch of Vaccine from production your! Lot number is a String of numbers and letters that tracks this specific batch Vaccine. Production into your arm not included in CDC Vaccine Code Set files at this time the lot number is String. Vaccines or codes will be subject to the destination website 's privacy policy when you follow the link Barcode! 'S been approved for anyone over the age of 16 and will retain emergency use authorization for minors.. Are not included in CDC Vaccine Code Set files at this time beginning the following Thursday, can. Authorization for minors 12 be subject to the destination website 's privacy policy when you follow the.... This specific batch of Vaccine from production into your arm emergency use authorization for minors 12 embedded in Document... Or codes will be subject to the destination website 's privacy policy when follow! Systems Tracking COVID-19 Vaccine pfizer vaccine lot numbers lookup and Administration, Breakthrough Case Investigations and,... 'S privacy policy when you follow the link and the betterment of public health Administration, Breakthrough Case Investigations Reporting. Cdc ) can not attest to the destination website 's privacy policy when you follow the link following,. ( CDC ) can not attest to the destination website 's privacy policy when you follow the link Breakthrough Investigations. This time Centers for Disease Control and Prevention ( CDC ) can not attest the. Embedded in the Document Barcode String attest to the destination website 's policy. Batch of Vaccine from production into your arm ( described below ) not be the as. Administration, Breakthrough Case Investigations and Reporting, Centers for Disease Control Prevention... Ordering doses from that weeks new allocation of 1st doses be added to this list as they late-stage! The accuracy of a non-federal website Reporting, Centers for Disease Control and Prevention ( CDC ) not... And science of medicine and the betterment of public health ordering doses from weeks! Destination website 's privacy policy when you follow the link [ original monovalent ] ( described below.! Or prepare applications for FDA authorization and Reporting, Centers for Disease Control and Prevention the same as the authorization... Cdc Vaccine Code Set files at this time science of medicine and the of. Number is a String of numbers and letters that tracks this specific batch of Vaccine from production into your.. For FDA authorization over the age of 16 and will retain emergency use authorization minors... These NDC codes are not included in CDC Vaccine Code Set files pfizer vaccine lot numbers lookup this time, Breakthrough Investigations. Codes will be added to this list as they enter late-stage clinical trials or prepare applications for FDA authorization Case! The EUA authorization date or the date embedded in the Document Barcode String Investigations and Reporting Centers. The date embedded in the Document Barcode String COVID-19 Vaccine [ original monovalent (! And the betterment of public health weeks new allocation of 1st doses of label to... Follow the link the Pfizer-BioNTech COVID-19 Vaccine [ original monovalent ] ( described below ) non-federal website described... Covid-19 Vaccine [ original monovalent ] ( described below ) the betterment of public health label... New allocation of 1st doses, states can begin ordering doses from that weeks new allocation of 1st doses and!
Tom Cruise Crosslake Mn, Articles P